Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
|
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Loss |
Total |
| Beginning Balance, Shares at Mar. 31, 2019 |
20,765,592
|
|
|
|
|
| Beginning Balance, Amount at Mar. 31, 2019 |
$ 20,766
|
$ 15,971,905
|
$ (13,425,879)
|
$ (339,888)
|
$ 2,226,904
|
| Issuance of common shares, net of offering costs, Shares |
14,338
|
|
|
|
|
| Issuance of common shares, net of offering costs, Amount |
$ 14
|
142,903
|
|
|
142,917
|
| Exercise of warrants, Shares |
2,500
|
|
|
|
|
| Exercise of warrants, Amount |
$ 2
|
25,998
|
|
|
26,000
|
| Restricted shares issued as stock- based compensation to consultants and investor relations, Shares |
20,500
|
|
|
|
|
| Restricted shares issued as stock- based compensation to consultants and investor relations, Amount |
$ 21
|
191,928
|
|
|
191,949
|
| Foreign currency translation adjustment |
|
|
|
(23,152)
|
(23,152)
|
| Net loss |
|
|
(2,368,305)
|
|
(2,368,305)
|
| Ending Balance, Shares at Sep. 30, 2019 |
20,802,930
|
|
|
|
|
| Ending Balance, Amount at Sep. 30, 2019 |
$ 20,803
|
16,332,734
|
(15,794,184)
|
(363,040)
|
196,313
|
| Beginning Balance, Shares at Jun. 30, 2019 |
20,801,680
|
|
|
|
|
| Beginning Balance, Amount at Jun. 30, 2019 |
$ 20,802
|
16,320,359
|
(14,677,144)
|
(355,639)
|
1,308,378
|
| Restricted shares issued as stock- based compensation to consultants and investor relations, Shares |
1,250
|
|
|
|
|
| Restricted shares issued as stock- based compensation to consultants and investor relations, Amount |
$ 1
|
12,375
|
|
|
12,376
|
| Foreign currency translation adjustment |
|
|
|
(7,401)
|
(7,401)
|
| Net loss |
|
|
(1,117,040)
|
|
(1,117,040)
|
| Ending Balance, Shares at Sep. 30, 2019 |
20,802,930
|
|
|
|
|
| Ending Balance, Amount at Sep. 30, 2019 |
$ 20,803
|
16,332,734
|
(15,794,184)
|
(363,040)
|
196,313
|
| Beginning Balance, Shares at Mar. 31, 2020 |
20,850,848
|
|
|
|
|
| Beginning Balance, Amount at Mar. 31, 2020 |
$ 20,851
|
16,589,272
|
(17,586,075)
|
(336,992)
|
(1,312,944)
|
| Issuance of common shares, net of offering costs, Shares |
1,994,924
|
|
|
|
|
| Issuance of common shares, net of offering costs, Amount |
$ 1,995
|
14,791,484
|
|
|
14,793,479
|
| Exercise of warrants, Shares |
37,933
|
|
|
|
|
| Exercise of warrants, Amount |
$ 38
|
394,437
|
|
|
394,475
|
| Restricted shares issued as stock- based compensation to consultants and investor relations, Shares |
10,000
|
|
|
|
|
| Restricted shares issued as stock- based compensation to consultants and investor relations, Amount |
$ 10
|
63,190
|
|
|
63,200
|
| Foreign currency translation adjustment |
|
|
|
(14,510)
|
(14,510)
|
| Net loss |
|
|
(2,681,273)
|
|
(2,681,273)
|
| Ending Balance, Shares at Sep. 30, 2020 |
22,893,705
|
|
|
|
|
| Ending Balance, Amount at Sep. 30, 2020 |
$ 22,894
|
31,838,383
|
(20,267,348)
|
(351,502)
|
11,242,427
|
| Beginning Balance, Shares at Jun. 30, 2020 |
21,282,133
|
|
|
|
|
| Beginning Balance, Amount at Jun. 30, 2020 |
$ 21,282
|
20,957,486
|
(18,686,131)
|
(332,169)
|
1,960,468
|
| Issuance of common shares, net of offering costs, Shares |
1,601,572
|
|
|
|
|
| Issuance of common shares, net of offering costs, Amount |
$ 1,602
|
10,817,707
|
|
|
10,819,309
|
| Restricted shares issued as stock- based compensation to consultants and investor relations, Shares |
10,000
|
|
|
|
|
| Restricted shares issued as stock- based compensation to consultants and investor relations, Amount |
$ 10
|
63,190
|
|
|
63,200
|
| Foreign currency translation adjustment |
|
|
|
(19,333)
|
(19,333)
|
| Net loss |
|
|
(1,581,217)
|
|
(1,581,217)
|
| Ending Balance, Shares at Sep. 30, 2020 |
22,893,705
|
|
|
|
|
| Ending Balance, Amount at Sep. 30, 2020 |
$ 22,894
|
$ 31,838,383
|
$ (20,267,348)
|
$ (351,502)
|
$ 11,242,427
|